Liu Z - Search Results

1

Current knowledge of protein palmitoylation in gliomas.

Tang F, Liu Z, Chen X, Yang J, Wang Z, Li Z. Tang F, et al. Among authors: liu z. Mol Biol Rep. 2022 Nov;49(11):10949-10959. doi: 10.1007/s11033-022-07809-z. Epub 2022 Aug 31. Mol Biol Rep. 2022. PMID: 36044113 Review.

2

Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma.

Tang F, Pan Z, Wang Y, Lan T, Wang M, Li F, Quan W, Liu Z, Wang Z, Li Z. Tang F, et al. Among authors: liu z. Neurosci Bull. 2022 Sep;38(9):1069-1084. doi: 10.1007/s12264-022-00866-1. Epub 2022 Jun 7. Neurosci Bull. 2022. PMID: 35670952 Free PMC article. Review.

3

In Regard to Chen et al.

Tang F, Liu Z, Wang Z, Li Z. Tang F, et al. Among authors: liu z. Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):173. doi: 10.1016/j.ijrobp.2022.05.029. Epub 2022 Jul 4. Int J Radiat Oncol Biol Phys. 2022. PMID: 35798657 No abstract available.

4

Local and systemic effects of IDH mutations on primary glioma patients.

Tang F, Wang DW, Xi C, Yang JZ, Liu ZY, Yu DH, Wang ZF, Li ZQ. Tang F, et al. Immunology. 2023 Aug;169(4):503-514. doi: 10.1111/imm.13649. Epub 2023 Apr 13. Immunology. 2023. PMID: 37054988

5

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma.

Liu ZY, Lan T, Tang F, He YZ, Liu JS, Yang JZ, Chen X, Wang ZF, Li ZQ. Liu ZY, et al. BMC Cancer. 2023 May 9;23(1):420. doi: 10.1186/s12885-023-10883-6. BMC Cancer. 2023. PMID: 37161425 Free PMC article.

6

TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas.

Tang F, Chen X, Liu JS, Liu ZY, Yang JZ, Wang ZF, Li ZQ. Tang F, et al. Discov Oncol. 2023 Aug 11;14(1):148. doi: 10.1007/s12672-023-00760-w. Discov Oncol. 2023. PMID: 37566174 Free PMC article.

7

The Role of Beta2-Microglobulin in Central Nervous System Disease.

Liu ZY, Tang F, Yang JZ, Chen X, Wang ZF, Li ZQ. Liu ZY, et al. Cell Mol Neurobiol. 2024 May 14;44(1):46. doi: 10.1007/s10571-024-01481-6. Cell Mol Neurobiol. 2024. PMID: 38743119 Free PMC article. Review.

8

Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics.

Wang B, Feng Y, Li Z, Zhou F, Luo J, Yang B, Long S, Li X, Liu Z, Li X, Chen J, Wang L, Wei W. Wang B, et al. Among authors: liu z. Life Sci. 2024 Jan 1;336:122312. doi: 10.1016/j.lfs.2023.122312. Epub 2023 Nov 30. Life Sci. 2024. PMID: 38042284 Free article.

9

The prognostic impact of tumor location in non-muscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing chinese multicenter and SEER registries.

Liu L, Li K, Wang SG, Wang J, Yao Z, Xie Y, Ji Z, Chen Z, Hu H, Chen H, Hu J, Hou Y, Liu Z, Li Y, Ding Y, Kuang Y, Xun Y, Hu J, Zhang J, Li H, Chong T, Bi J, Wang Z, Wang Y, Zhang P, Wei Q, Chen Z, Li L, Huang J, Liu Z, Chen K; Chinese Bladder Cancer Consortium. Liu L, et al. Among authors: liu z. Int J Surg. 2024 May 24. doi: 10.1097/JS9.0000000000001675. Online ahead of print. Int J Surg. 2024. PMID: 38788195

10

Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.

Qi C, Zhang P, Liu C, Zhang J, Zhou J, Yuan J, Liu D, Zhang M, Gong J, Wang X, Li J, Zhang X, Li N, Peng X, Liu Z, Yuan D, Baffa R, Wang Y, Shen L. Qi C, et al. Among authors: liu z. J Clin Oncol. 2024 May 24:JCO2302314. doi: 10.1200/JCO.23.02314. Online ahead of print. J Clin Oncol. 2024. PMID: 38788174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83,128 results

Search Page